GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Physitrack PTRK.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

11.25

+6.64%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€13.8m

FY2016FY2025

Net income

−€6.9m

FY2016FY2025

Free cash flow

€3.9m

FY2016FY2025

Shareholders' equity

€10.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue€13.8m€16.2m€15.2m€12.5m€7.8m€5.8m€1.2m€857,000€447,410€237,564
Operating income€518,126−€6.5m€3.4m€109,387€1.0m€916,717−€200,236−€161,930€447,410€237,564
Net income−€6.9m−€6.5m€3.2m€92,319−€815,035€688,409−€205,914−€206,716−€78,131−€359,624
Diluted earnings per share-0.43-0.400.200.01-0.060.06-0.01-0.01-0.00-0.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€19.2m€30.5m€38.7m€41.3m€32.3m€11.9m€1.8m€2.0m€1.9m€2.0m
Cash and short-term investments€654,298€723,386€536,029€577,742€13.3m€775,550€12,251€94,347——
Total liabilities€9.2m€11.3m€13.1m€18.9m€3.6m€6.8m€794,632€832,138€533,227€515,260
Debt€3.9m€4.8m€3.6m€831,663€1,310€2.0m€417,252€410,605——
Shareholders' equity€10.0m€19.2m€25.6m€22.4m€23.3m€5.2m€1.0m€1.2m€1.4m€1.5m
Shares outstanding16m16m16m16m14m11m16m16m16m16m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€3.9m€3.1m€2.6m€1.5m€659,810€2.0m€500,894€705,601€549,274—
Capital spending−€30,444−€3.5m−€3.4m−€4.5m−€5,759−€978,252−€560,084−€746,194——
Free cash flow€3.9m−€363,543−€773,782−€3.0m€654,051€1.1m−€59,190−€40,593€549,274—

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Dec 2025Nov 2025Sept 2025Aug 2025Jun 2025
Revenue€3.7m€3.4m€3.2m€3.3m€3.3m€3.5m€3.5m€3.5m
Operating income€248,040€243,799€108,526€185,100€186,582−€75,900−€195,326€181,400
Net income€141,519−€69,376−€15,879−€7.9m−€7.9m−€354,400−€354,383−€150,400
Diluted earnings per share0.01-0.00-0.00-0.48-0.49-0.02-0.02-0.01
Cash from operations€1.0m———€1.0m—€1.0m—
Total assets€19.1m€18.6m€18.7m€19.2m€19.2m€26.9m€26.9m€27.7m
Cash and short-term investments€485,310€398,162€435,906€656,600€654,298€603,300€603,335€467,500
Debt—€4.3m€4.0m€3.9m€3.9m€4.0m€4.0m€4.3m
Shareholders' equity€10.1m€9.9m€10.0m€10.0m€10.0m€17.7m€17.7m€18.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.3%18.8%77.6%
Operating income67.9%-10.8%—
Net income——32.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-20.0%-4.2%-0.7%-0.8%
Net margin-44.7%-17.5%-14.3%-15.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-2.8-2.07.5384.0-89.0
Price to sales1.40.81.62.89.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.